Sartorius | SRT3 - Current Assets

Stock Price
209.00
Daily Change
-0.70 -0.33%
Monthly
-7.36%
Yearly
-15.56%
Q1 Forecast
203.68

Sartorius reported EUR1.72B in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Akebia Therapeutics USD 252.96M 5.38M Dec/2025
Alaunos Therapeutics USD 2.68M 1.05M Sep/2025
Avita Medical AUD 35.49M 760K Dec/2025
Dianthus Therapeutics USD 409.44M 4.39M Dec/2025
Ionis Pharmaceuticals USD 2.99B 471.01M Dec/2025
IQVIA Holdings USD 6.25B 270M Dec/2025
Moderna USD 6.54B 54M Dec/2025
Organon & Co USD 4.7B 82M Sep/2025
Revvity USD 2.24B 95.96M Dec/2025
Sartorius EUR 1.72B 449M Sep/2025
Tectonic Therapeutic USD 273.24M 17.61M Sep/2025
Viatris USD 9.79B 162.2M Dec/2025
Xeris Pharmaceuticals USD 224.02M 38.44M Sep/2025